Medication Options for Alcohol Use Disorder

Alcohol Use Disorder (AUD) affects millions of Americans, creating profound impacts on physical health, mental well-being, and quality of life. While many people are familiar with 12-step programs and behavioral therapy approaches to alcohol recovery, fewer understand the valuable role that medication can play in treatment. For Alcohol Awareness Month, we’re exploring the FDA-approved Medications For Addiction Treatment (MAT) that can significantly improve recovery outcomes when combined with behavioral support.

Understanding Medication-Assisted Treatment for Alcohol Misuse & Addiction

Medications for Addiction Treatment (MAT) combines medications with counseling and behavioral therapies to provide a “whole-patient” approach to treating alcohol use disorder. This evidence-based approach has been shown to:

• Reduce alcohol cravings
• Decrease the likelihood of relapse
• Help maintain long-term sobriety
• Address underlying neurobiological changes caused by chronic alcohol use

At Porch Light Health, we understand that recovery from alcohol use disorder is not about willpower or determination—it’s about addressing the complex biological, psychological, and social factors that contribute to addiction. Our comprehensive treatment programs incorporate Food and Drug Administration (FDA)-approved medications that can make the difference between successful recovery and ongoing struggles with alcohol dependence.

Related: Signs You Need to Stop Drinking

FDA-Approved Medications for Alcohol Use Disorder

The FDA has approved three medications specifically for treating alcohol use disorder, each working through different mechanisms to support recovery. These evidence-based treatments have been thoroughly studied and proven effective when appropriately prescribed and monitored by medical professionals. Let’s explore each option and how it might benefit your recovery journey.

1. Naltrexone (Oral and Injectable Forms)

Naltrexone works by blocking the pleasurable effects of alcohol in the brain, reducing the “reward” associated with drinking. This medication is available in two forms:

Oral Naltrexone (ReVia®, Depade®)

Oral naltrexone is typically taken once daily and can help reduce alcohol cravings and the urge to drink. It’s especially effective for people who:

• Have already stopped drinking and want to maintain abstinence
• Are still drinking but want to reduce their alcohol consumption
• Have a history of relapse and need additional support

A meta-analysis of controlled clinical trials found that short-term naltrexone treatment was linked with “a lower percentage of drinking days, fewer drinks per drinking day, longer times to relapse, more days of abstinence, and lower total alcohol consumption during treatment” compared to placebo. 

Injectable Naltrexone (Vivitrol®)

Vivitrol is a once-monthly injection that continuously releases naltrexone over 30 days. This extended-release formulation offers several advantages:

• Eliminates the need for daily medication
• Ensures consistent medication levels between appointments
• Reduces compliance issues common with daily oral medications
• May be particularly helpful for individuals who struggle with medication adherence

Studies indicate that patients receiving Vivitrol injections have significantly fewer drinking days per month and experience a 25% greater reduction in heavy drinking compared to those taking a placebo.

2. Acamprosate (Campral®)

Acamprosate works differently than naltrexone, focusing on restoring the balance of neurotransmitters disrupted by chronic alcohol use. This medication:

• Helps the brain establish a new normal state without alcohol
• Reduces alcohol cravings and withdrawal symptoms, particularly anxiety and insomnia
• Typically taken three times daily
• Works best for individuals who have already achieved abstinence and want to maintain it

Clinical trials show that acamprosate can significantly increase the rate of complete abstinence and extend the time before the first drink in recovering individuals. It’s particularly effective when combined with counseling and support groups.

3. Disulfiram (Antabuse®)

Disulfiram takes a different approach to treating alcohol use disorder by creating an unpleasant physical reaction when combined with alcohol. When someone taking disulfiram consumes alcohol, they may experience:

• Nausea and vomiting
• Headache
• Flushing
• Chest pain
• Rapid heart rate
• Breathing difficulties

This medication works by inhibiting aldehyde dehydrogenase, the enzyme that breaks down acetaldehyde (a toxic byproduct of alcohol metabolism). As a result, acetaldehyde builds up in the body, causing these uncomfortable reactions.

Disulfiram is typically recommended for individuals who:

• Are highly motivated to maintain complete abstinence
• Have a support system that can help ensure medication compliance
• Have tried other treatments without success
• Don’t have contraindications like certain heart conditions or pregnancy

It’s important to note that disulfiram should only be used under close medical supervision and is not appropriate for everyone with alcohol use disorder.

The Role of Topiramate and Gabapentin

While not explicitly FDA-approved for alcohol use disorder, two additional medications have shown promise in treating AUD and are sometimes prescribed off-label:

1. Topiramate (Topamax®)

Topiramate was initially developed to treat seizures but has demonstrated effectiveness in reducing alcohol consumption and cravings. This medication:

• Decreases dopamine release associated with alcohol consumption
• Reduces glutamate activity while enhancing GABA (an inhibitory neurotransmitter)
• It may help address both the rewarding effects of alcohol and withdrawal symptoms
• It is typically started at a low dose and gradually increased over several weeks

Research shows that topiramate can significantly reduce heavy drinking days and increase abstinence rates compared to placebo.

2. Gabapentin (Neurontin®)

Gabapentin, another medication initially developed for seizure disorders, has shown effectiveness in treating alcohol withdrawal symptoms and reducing relapse rates. It may be particularly helpful for individuals who experience:

• Insomnia during early recovery
• Anxiety as part of withdrawal
• Cravings triggered by stress

Studies indicate that gabapentin can improve sleep, reduce anxiety, and decrease alcohol consumption in people with alcohol use disorder, particularly those with more severe withdrawal symptoms.

Related: Understanding Wet Brain: Wernicke-Korsakoff Syndrome

Combining Medication with Behavioral Therapies

At Porch Light Health, we emphasize that medication is most effective when combined with appropriate behavioral health services. Our comprehensive approach includes:

• Individual counseling: One-on-one sessions address the psychological aspects of alcohol dependence and develop personalized coping strategies
• Group therapy: Peer support provides additional accountability and shared experiences that promote recovery
• Case management: Assistance with practical needs like healthcare access, employment, and housing that can impact recovery success
• Family involvement: Education and support for loved ones to create a healthier recovery environment

The combination of medication and behavioral therapy addresses both the biological and psychological aspects of alcohol use disorder, significantly improving long-term outcomes.

Related: The Sinclair Method for AUD

Finding the Right Medication: A Personalized Approach

There is no one-size-fits-all approach to medication for alcohol use disorder. The right medication depends on numerous factors, including:

• Medical history and current health status
• Previous treatment experiences
• Drinking patterns and severity of alcohol use disorder
• Co-occurring mental health conditions
• Personal preferences and goals (abstinence vs. reduced consumption)
• Logistical considerations like insurance coverage and the ability to manage daily medications

At Porch Light Health, our medical providers conduct thorough assessments to determine the most appropriate medication option for each individual. We consider not only the clinical factors but also practical considerations to ensure treatment success.

Overcoming Barriers to Medications for Addiction Treatment

Despite strong evidence supporting medications for addiction treatment for AUD, several barriers prevent wider use:

1. Misunderstanding and Stigma

Many people incorrectly believe that using medication for alcohol recovery means “substituting one addiction for another” or that it’s not “real recovery.” This stigma can prevent individuals from seeking or continuing medication treatment.

In reality, FDA-approved medications for AUD do not create new addictions and can be vital tools in achieving long-term recovery. Porch Light Health educates patients and families to address these misconceptions.

2. Limited Provider Knowledge

Many healthcare providers receive minimal training in addiction treatment and may be unfamiliar with medication options for alcohol use disorder. This can result in missed opportunities to offer effective treatments.

Our medical team at Porch Light Health specializes in addiction medicine and stays current with the latest research and best practices in MAT.

3. Access and Insurance Challenges

Cost and insurance coverage can be significant barriers to medication treatment. Some medications, particularly newer formulations, may be expensive or have limited insurance coverage.

We work with patients to navigate insurance requirements and find affordable medication options, including assistance programs when available.

Our Porch Light Is Always On

With over 60 locations across Colorado and New Mexico, Porch Light Health provides accessible, evidence-based treatment for alcohol use disorder. Our team understands the challenges of recovery and is committed to providing compassionate, effective care.

Contact us today at (866) 394-6123 to schedule a confidential assessment and learn more about how Medications for Addiction Treatment (MAT) might benefit your recovery journey. You don’t have to face alcohol use disorder alone—we’re here to help you find your way to a life beyond addiction.

References

1. Singh D, Saadabadi A. Naltrexone. [Updated 2023 May 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534811/

2. Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. (Treatment Improvement Protocol (TIP) Series, No. 49.) Chapter 4—Oral Naltrexone. Available from: https://www.ncbi.nlm.nih.gov/books/NBK64042/

3. Medical News Today. (2022, June 11). Vivitrol injection (naltrexone): Side effects, dosage, and more. https://www.medicalnewstoday.com/articles/326499

4. Yahn, S. L., Watterson, L. R., & Olive, M. F. (2013). Safety and efficacy of acamprosate for the treatment of alcohol dependence. Substance abuse : research and treatment, 6, 1–12. https://doi.org/10.4137/SART.S9345

5. Votaw, V. R., Witkiewitz, K., Van Horn, M. L., Crist, R. C., Pond, T., & Kranzler, H. R. (2023). An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial. Addiction (Abingdon, England), 118(6), 1040–1052. https://doi.org/10.1111/add.16126

6. Anton, R. F., Latham, P., Voronin, K., Book, S., Hoffman, M., Prisciandaro, J., & Bristol, E. (2020). Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA internal medicine, 180(5), 728–736. https://doi.org/10.1001/jamainternmed.2020.0249